secwatch.observer — SEC 8-K summary
======================================

Issuer:     Ensysce Biosciences, Inc. (ENSC)
CIK:        0001716947
Form:       8-K
Filed at:   2024-05-09T23:59:59+00:00
Accession:  0001493152-24-018482
Event type: regulatory
Sentiment:  positive
Materiality: 0.65
Item codes: 8.01
LLM model:  deepseek-v4-flash:cloud@v2

Ensysce Biosciences believes it regains Nasdaq stockholders' equity compliance after warrant exercise
--------------------------------------------------------------------------------

- Company believes it now has at least $2.5M stockholders' equity, satisfying Nasdaq listing rule.
- February 2024 warrant exercise generated gross proceeds of ~$4.7M.
- Previously received Nasdaq extension to May 13, 2024 to evidence compliance.
- Awaiting Nasdaq formal confirmation of compliance status.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1716947/000149315224018482/0001493152-24-018482-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1716947/000149315224018482/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-24-018482

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer